Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Bandage choice may speed hip surgery recovery, small trial hints

NCT ID NCT07655388

Knowledge-focused Sponsor: Clinical Center of Vojvodina Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jul 10, 2026 · Updated 2 times

Summary

This study tests whether the type of wound dressing and how often it's changed can improve healing after hip replacement surgery. Ninety patients aged 65 and older will be randomly assigned to receive either a special capillary-action dressing (VACUTEX™) or standard dressings changed at different intervals. Researchers will track how quickly the wound closes, pain levels, and any complications, aiming to find the best wound care routine.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
VACUTEX™ wound dressing (device) and Octenisept® wound care dressing (procedure)
What this could lead to
If successful, this could point toward better wound care routines after hip replacement, potentially reducing complications and speeding up healing.
What could go wrong
This is a small, early-stage study (90 people) focused on observation, not a treatment. Results may not apply to all patients or settings, and no major breakthrough is expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 to 95 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients scheduled for primary total hip arthroplasty (THA) * Age ≥ 65 years * Ability to provide informed consent * Patients with closed surgical incision suitable for standard postoperative wound care Exclusion Criteria: * Revision hip arthroplasty * Active infection at the time of surgery * Immunosuppressive therapy or severe immunodeficiency * Known allergy to dressing materials used in the study * Severe peripheral vascular disease affecting wound healing * Inability to comply with follow-up protocol

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Total hip arthroplasty (THA) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pain, Postoperative Surgical Wound Surgical Wound Infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Total hip arthroplasty (THA) Wound healing time

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Clinic for Orthopedic Surgery and Traumatology, University Clinical Center of Vojvodina

    RECRUITING

    Novi Sad, 21000, Serbia

More trials for these conditions

Other studies related to the condition(s) this trial covers.